(Updated - June 3, 2025 8:14 AM EDT)

Oppenheimer analyst Jay Olson initiates coverage on Axsome Therapeutics (NASDAQ: AXSM) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE